118th Congress · SENATE BILLBILL

S. 36 — Agility in Manufacturing Preparedness Act of 2023

“A bill to review domestic biopharmaceutical manufacturing capabilities in order to improve public health and medical preparedness and response capabilities and domestic biopharmaceutical manufacturing capabilities.”

Health

Introduced Jan 24, 2023

Last action Jan 24, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jan 24, 2023

Step 2

Referred

Jan 24, 2023

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill requires the Department of Health and Human Services (HHS) to seek to contract with the National Institute for Innovation in Manufacturing Biopharmaceuticals to assess and make recommendations concerning U.S. capabilities for biopharmaceutical manufacturing and related matters. HHS must coordinate with the Biomedical Advanced Research and Development Authority on this contract.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Jan 24, 2023

Introduced in Senate

Jan 24, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.